Condition: Idiopathic Cardiomyopathy · Left Ventricular (LV) Systolic Dysfunction · Non-ischemic Cardiomyopathy · Sponsor: Berlin Heals GmbH
Patients with idiopathic dilated cardiomyopathy in heart failure (NYHA class III - IV) with a baseline left ventricular ejection fraction between ≥25% and ≤35%, and patients with non-ischemic cardiomyopathy in heart failure (NYHA class III-IV) with a baseline left ventricular ejection fraction \>40% and \<50% despite guideline-directed medical therapy, will receive C-MIC treatment in addition to optimal medical management. The device can be implanted without the need for open-heart surgery. Patients are assigned to one of two groups according to the indications under investigation. At the end of the study after 6 months, the C-MIC System will be turned off. The primary endpoint of the study is the absolute change in left ventricular ejection fraction after 6 months of treatment.
This description comes directly from the study's public registry record.
Susanne Becker · +49 308891364053 · becker@berlinheals.de
John Brumfield · +49 308891364053 · brumfield@berlinheals.de
Always discuss trial participation with your own doctor first.
| University Clinical Center of the Republic of Srbska | Banja Luka, Republic of Srbska, Bosnia and Herzegovina | Recruiting |
| Institute of Cardiovascular Disease Dedinje | Belgrade, Serbia | Recruiting |
| Clinical Hospital Center Bezanijska kosa | Belgrade, Serbia | Recruiting |
| UKC Kragujevac | Kragujevac, Serbia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06920030